Dermatitis News

Regeneron Pharmaceuticals and Sanofi announced that the U.S. Food and Drug Administration has granted breakthrough therapy designation to dupilumab for adults with moderate-to-severe atopic dermatitis who are not adequately controlled with topical prescription therapy or for whom such treatments are not appropriate.

Children with atopic dermatitis had an increased risk for peanut skin prick test sensitization and peanut allergy when exposed to peanut antigen in dust, according to recent study results.

ATLANTA — Thursday’s all-day special session at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting focused on skin-related allergies and the use of patch testing for allergic contact dermatitis.

Oral swab testing provided more precise concentrations and acceptable detection of cytokines related to allergic inflammation in children compared with passive drool collection, according to recent study results.

Regeneron Pharmaceuticals and Sanofi have announced the start of a phase 3 clinical trial of dupilumab in adults with moderate-to-severe atopic dermatitis not adequately controlled with topical medications, according to a press release.

Sublingual immunotherapy with a standardized house dust mite extract was more effective in treating children with atopic dermatitis and house dust mite sensitization compared with standard treatment, according to recent study results.

Emollient therapy from birth was an effective method of preventing atopic dermatitis in infants, according to recent study results.

A need exists for large-scale, randomized, controlled trials of systemic treatment for atopic dermatitis that include more racial and ethnic diversity to better represent the diverse U.S. population, according to a literature review.

Research on predicting and possibly reducing food allergies in infancy was presented at the Food Allergy and Anaphylaxis Meeting, organized by the European Academy of Allergy and Clinical Immunology, in Dublin.

Vitamin D supplementation was effective in treating winter-related atopic dermatitis in Mongolian children who were at high risk for vitamin D deficiency when compared with placebo in a recent study.